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The finding of high concentrations of oestrogen receptors in
the cytoplasm and nucleus of both human and experimental
animal pancreatic adenocarcinoma cells (Greenway et al.,
1981; Satake et al., 1982), and subsequent demonstration of
an apparent dependence of pancreatic cancer cells on
circulating sex steroids (Greenway et al., 1982; Iqbal et al.,
1983) has led to a series of human and animal studies of
hormonal manipulation as a possible new approach to the
treatment of pancreatic cancer (Crowson et al., 1986, 1987;
Greenway, 1982, 1987, 1988; Kloppel et al., 1986; Redding et
al., 1984; Theve et al., 1983; Tonneson et al., 1986; Wong et
al., 1987).
Because pancreatic cancer induced in the Syrian hamster
by N-nitrosobis (2-oxopropyl) amine (BOP) resembles
human pancreatic cancer in many ways (Pour et al., 1981),
we studied the effect of surgical oophorectomy in this animal
model. Female Syrian hamsters (Bantin and Kingman Ltd,
The Field Station, Grimston, Hull, n=60; age, 5 weeks) were
housed with a 12-h light/dark cycle and were given free
access to Purina Laboratory Chow and water. Following
acclimatisation, one group of 30 hamsters underwent
laparotomy and bilateral oophorectomy through a midline
incision, while a second group (n =30) underwent sham
operations where the ovaries were simply touched before
closure of the abdomen. All animals were anaesthetised using
intraperitoneal Hypnorm (Fentanyl citrate with Fluanisone)
and Midazolam (1 part Hypnorm, 2 parts water and I part
Midazolam; 4.5mlkg-1). Two weeks postoperatively all
hamsters received a course of four weekly subcutaneous
injections of BOP (Ash Stevens, Detroit, MI, USA)
(10mgkg-1, made up fresh in normal saline solution).
Thirty weeks following the first BOP injection, all
surviving animals were killed by an overdose of carbon
dioxide. Each pancreas was removed by dissection of its
three lobes from surrounding structures, and after trimming
of peripancreatic fat, each organ was weighed. The
anatomical surfaces of each liver and lung were also
examined, and any abnormal areas were removed and fixed
in 10% formalin for histological examination. Sections
through each pancreas were cut at 5,um intervals, the
number of sections varying according to the size of the
pancreas and any tumours within it. All tissues were stained
with Haematoxylin & Eosin for histological examination on
coded slides. The x2 test was used to compare the incidence
of pancreatic cancer.
All animals gained weight equally following surgery
(Table I) and 57 (95%) survived to the end of the
experiment. There was no difference in the incidence of
pancreatic cancer between the two groups: 45% in the
oophorectomy group and 50% in controls (Table I). One
hamster in the control group developed an islet cell
pancreatic carcinoma in addition to an adenocarcinoma, but
there were no other instances where multiple tumours
occurred. The incidence of hamsters bearing bronchial
neoplasms was similar in all animals (9/29 (31%) in the
oophorectomy group, and 8/28 (28%) in controls). Although
a number of hamsters developed hepatic cysts, there were no
hepatic cancers.
In experimental animals, hormonal manipulation using
long-acting gonadotrophin antagonists has been found to be
effective in inhibiting the growth of cancers in the prostate,
mammary glands, pituitary and connective tissues (Schally et
al., 1984). Furthermore, the agonistic analogue of luteinising
hormone-releasing hormone (which paradoxically inhibits
pituitary and gonadal function after chronic administration)
decreases the weight and volume of chemically induced,
transplanted pancreatic cancers in both rats and hamsters
(Redding, 1984). In addition, gonadal ablation inhibits
azeserine-induced pancreatic carcinogenesis in male rats,
although opposite effects have been seen in female rats
undergoing oophorectomy (Lhoste et al., 1986). Despite
these findings, we found no effect of bilateral oophorectomy
on BOP-induced pancreatic carcinogenesis in the Syrian
hamster.
Recent studies on the effect of the anti-oestrogen
tamoxifen on inhibition of the growth of inoperable
pancreatic adenocarcinomas in human beings have been
conflicting (Crowson et al., 1986, 1987; Greenway, 1987,
1988; Theve et al., 1983; Tonneson et al., 1986; Wong et al.,
1987), but the results of further studies are awaited
(Greenway, 1987). In our study, the lack of effect of
oophorectomy on experimental pancreatic carcinogenesis has
been documented, but the contribution of the adrenals to
oestrogen production has not been assessed. In addition, the
presence of, or any change in, oestrogen receptor status of
the developing pancreatic cancers has not been determined.
The effect of ovarian ablation or of tamoxifen on the
development of established pancreatic cancers in this animal
model, together with an investigation of the steroid receptor
status of these experimental tumours now merits further
investigation.
Table I Body weights, pancreatic weights and incidence of pancreatic cancer for hamsters undergoing oophorectomy or sham operations and
receiving N-nitrosobis (2-oxopropyl) amine (BOP)
No. of animals Body wt (g) (±s.e.)_ Pancreatic wt Pancreatic/body wt No. animals with
Treatment Week I Week 30 Week 1 Week 30 (mg) (±s.e.) (mgg-1) (±s.e.) pancreatic cancer
Oophorectomy+BOP 30 29 114.1 +1.3 129.5 +3.8 658+25 5.135+0.17 13
Sham operation+BOP 30 28 108.8+1.5 126.4+2.0 672+32 5.31+0.16 14
Total 60 57 - - - - 27
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